Edwards Lifesciences plans to get out of the advanced patient monitoring business with a tax-free spinoff of its critical care business at the end of 2024.
Separated from Edwards, the new critical care company will have “increased focus and flexibility … to improve the quality of care for millions of patients around the world,” Edwards CEO...